Related Experiment Videos
Methylene 3, 4 dioxymethamphetamine-induced acute myocardial infarction
Ting-I Lai1, Juey-Jen Hwang, Cheng-Chung Fang
1Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Republic of China.
Annals of Emergency Medicine
|November 25, 2003
Summary
Methylene 3,4-dioxymethamphetamine (MDMA) use can cause rare but severe acute myocardial infarction. This case highlights the risk of coronary artery thrombosis following MDMA ingestion.
Area of Science:
- Cardiology
- Toxicology
- Pharmacology
Background:
- Methylene 3,4-dioxymethamphetamine (MDMA) is a popular recreational drug with known cardiovascular risks.
- While arrhythmias and heart failure are common, MDMA-induced acute myocardial infarction (AMI) is rarely documented.
Observation:
- A young man presented with acute myocardial infarction shortly after recreational MDMA use.
- Emergency angiography revealed massive thrombosis in the right coronary artery.
Findings:
- The patient was successfully treated with glycoprotein IIb/IIIa inhibitors and intracoronary urokinase.
- Coronary angiography post-treatment showed a patent artery without significant stenosis, suggesting a thrombotic event rather than atherosclerosis.
Implications:
- This case underscores the potential for MDMA to precipitate acute myocardial infarction through coronary thrombosis.
- Clinicians should consider MDMA toxicity in young patients presenting with myocardial infarction, even without typical risk factors.
- Further research into the mechanisms of MDMA-induced cardiovascular events is warranted.